Circulating tumor cells (CTCs) in biochemical recurrence (BR) of prostate cancer: Final results.

Authors

Jeanny Aragon-Ching

Jeanny B. Aragon-Ching

George Washington University Medical Center, Washington, DC

Jeanny B. Aragon-Ching , Samuel J. Simmens , Ramez Andrawis , Frederick Hendricks , Harold Frazier Jr., Michael Phillips , Thomas Jarrett , Steven R. Patierno , Robert S. Siegel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 179)

DOI

10.1200/jco.2013.31.6_suppl.179

Abstract #

179

Poster Bd #

B3

Abstract Disclosures

Similar Posters

Poster

2011 Genitourinary Cancers Symposium

Role of circulating tumor cells (CTCs) in biochemical recurrence (BR) of prostate cancer.

Role of circulating tumor cells (CTCs) in biochemical recurrence (BR) of prostate cancer.

First Author: Jeanny Aragon-Ching

First Author: Jeanny B. Aragon-Ching

First Author: Maria Paula Mogollon

Poster

2023 ASCO Genitourinary Cancers Symposium

Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.

Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.

First Author: Neha Debnath